TTK Healthcare reported FY26 revenue of ₹929.43 crore, a rise from last year. However, net profit saw a dip to ₹65.68 crore due to challenges in its Protective Devices segment and higher brand promotion costs.
TTK Healthcare Posts Revenue Growth, Profit Dip in FY26
Revenue from operations for TTK Healthcare for the financial year 2025-26 stood at ₹929.43 crore, an increase from ₹872.75 crore in the previous year. The company's Profit after Tax for FY26, however, declined to ₹65.68 crore from ₹81.66 crore reported in FY25. Earnings Per Share (EPS) was ₹46.48.
Reader Takeaway: Revenue growth offset by lower profits due to segment-specific challenges and increased spending.
What just happened
TTK Healthcare reported its financial results for the fiscal year ending March 31, 2026. Consolidated revenue from operations increased to ₹929.43 crore. However, Profit after Tax saw a decrease to ₹65.68 crore compared to ₹81.66 crore in the prior year. This profitability dip is attributed to operational challenges in the Protective Devices division, including the loss of institutional business from USAID and UNFPA, and increased expenditure on brand promotion for Consumer and Pleasure Products divisions.
Why this matters
While revenue growth is positive, the decline in net profit indicates margin pressures. Shareholders will be concerned about the factors affecting profitability, particularly the impact of losing key institutional tenders in the Protective Devices segment and rising promotional costs. The recommended dividend, however, shows a commitment to shareholder returns.
The backstory
TTK Healthcare has a diversified business model across various segments. The company has historically focused on providing consumer products, protective devices, and animal welfare products. The challenges in the Protective Devices segment related to institutional business have been a recurring theme, requiring strategic adjustments.
What changes now
The company needs to address the operational challenges in its Protective Devices division by securing new customers and exploring export opportunities. Increased focus on brand promotion for Consumer and Pleasure Products divisions is expected to drive future growth, though it impacts short-term profitability. The Foods division faces potential risks from raw material price volatility.
Risks to watch
Key risks include the continued impact of losing institutional/tender business in Protective Devices, potential volatility in raw material costs for the Foods division (like Maida), and broader geopolitical instability affecting input costs and supply chains, particularly concerning the West Asia crisis.
Peer comparison
While direct segment-wise profitability comparisons are challenging without specific peer data, companies in the consumer products space often face similar pressures from brand promotion costs and raw material price fluctuations. The Protective Devices segment faces unique challenges tied to institutional tenders.
Context metrics (time-bound)
- FY26 Revenue from Operations: ₹929.43 crore (vs. ₹872.75 crore in FY25)
- FY26 Profit after Tax: ₹65.68 crore (vs. ₹81.66 crore in FY25)
- Recommended Dividend: 100% (₹10 per share)
What to track next
Investors will be keen to observe the company's success in acquiring new clients for its Protective Devices segment and mitigating the impact of lost tenders. Monitoring the effectiveness of increased brand promotion spending and managing raw material costs in the Foods division will be crucial for future profitability.